Novartis holds itself to high standards of sustainability and ethical business conduct. Independent third-party ratings periodically assess us against selected environmental, social and governance (ESG) criteria.

Industry-leading performance across priority ESG ratings

RatingScore1Position / Status
Access to Medicine Index (ATMI)3.781st (among top 4 since 2014)
CDP Climate ChangeADouble A List status
CDP Water SecurityA
ISS ESGBLeader status
MSCIAALeader status
Sustainalytics*15.6Low Risk category

For more information on our awards and recognition, please click here.